iKang Healthcare (KANG) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
iKang (KANG) Reports Violation of Anti-Monopoly Law by Meinian Onehealth, Controlling Shareholder YU Rong
March 10, 2016 10:10 AM ESTiKang (Nasdaq: KANG) announces the submission of the report of the violation of anti-monopoly law by Meinian Onehealth Healthcare (Group) Co., Ltd. (Meinian Onehealth) and its ultimate controlling shareholder YU Rong, to the Anti-monopoly Bureau of the Ministry of Commerce of the Peoples Republic of China (MOFCOM).
Meinian Onehealth recently announced their intention to purchase an aggregate of 72.22% of the equity interest in CiMing Health Checkup Management Group Co., Ltd. (CiMing Checkup) from Shanghai Tianyi Asset Management Co., Ltd. (Tianyi), Beijing Dongsheng Kangye Investment Consultancy Co., Ltd., HAN Xiaohong and LI Shihai, following which... More
